COVID-19 antibody cocktail might be available soon, human trials by June: Regeneron
Image Credit: shortpedia
Regeneron Pharma is developing an antibody cocktail so that it can make clinical data available within a month or so after initiating the studies. Its experimental antibody cocktail for COVID-19 may be available for use by summer or fall end as the company ramps up efforts to start human trials in June. The company will be testing the antibody cocktail in 3 different settings to check its effectiveness in the early stage of the disease.